Neuropsychopharmacology
- Trajectories of mental health and mental illness: where we are now and where we go next9 months ago
- Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects9 months ago
- Integrating multi-polygenic scores for enhanced prediction of antidepressant treatment outcomes in an East Asian population9 months ago
- Hyper-maturity and accelerated aging in the hippocampus of mouse models of neuropsychiatric disorders with anxiety-like behavior9 months ago
- Investigating hierarchical critical periods in human neurodevelopment9 months ago
- DKK2 contributes to context discrimination and adult hippocampal neurogenesis by suppressing Wnt/PCP signaling9 months ago
- In memoriam—Donald A. Overton, Ph.D10 months ago
Journal of Psychopharmacology
- Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model1 year ago
- Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study1 year ago
- A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report1 year ago
- Lifetime classic psychedelic use and headaches: A cross-sectional study1 year ago
- A three-stage strategy for conducting an experimental investigation: A recommendation to improve the reproducibility of reported conclusions1 year ago
- Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study1 year ago
- Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder1 year ago
European Neuropsychopharmacology
- Disease-wide association study uncovers disease continuum network of unipolar depression2 years ago
- Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis2 years ago
- Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach2 years ago
- Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?2 years ago
- Opportunities to advance microRNA research in psychiatry2 years ago
- Respiratory health in serious mental illness2 years ago
- Genomic evidence of GLP-1 receptor as target for the treatment of substance use disorders2 years ago